Project Grant R41DA059281
Award Date
8/15/24
Completion Date
7/31/25
Dollars Obligated
$290K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Mt Pleasant, SC 29466, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) awarded a $294,489 Project Grant under CFDA 93.279, the Drug Use and Addiction Research Programs, to See Yourself Health LLC, a woman-owned small business. The funding will support the development and feasibility testing of the CHIRON PROJECT, an immersive virtual reality platform designed to help healthcare workers manage burnout and prevent substance use disorders. The key products and services to be delivered under this Phase I award include: 1)...
This $1,534,938 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a randomized controlled trial to evaluate an immersive mindfulness virtual reality (VR) intervention for chronic pain and opioid use disorder (OUD) in opioid treatment programs. The grant will support enrollment and randomization of 185 participants with chronic pain and OUD at opioid treatment programs in the Bronx, New York to receive...
This Project Grant award of $610,092 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will develop and evaluate a hybrid substance use prevention program for upper elementary school students. The program will utilize both online e-learning modules and traditional classroom sessions to teach students about the harms of vaping and prescription drug misuse, while enhancing protective factors by building social and self-regulation...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (part of the National Institutes of Health), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $305,909 to Goalistics LLC, a for-profit business located in Tempe, AZ. The funding supports the development of a psychologist/nurse practitioner-guided internet-based chronic pain self-management program delivered via telehealth. Specifically, the project aims to 1) create training...
This $1,607,146 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development of community-based technology interventions to encourage drug checking, distribution of harm reduction supplies, and linkage to substance use disorder treatment services. The recipient, NDRI-USA Inc., a non-profit research organization, will use a participatory design process to create multimedia content in English...
The federal Project Grant award R43DA059490 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $959,964 award will fund the design and feasibility demonstration of a prototype system called "Stimulant Use Recovery via Immersive Virtual Environments (SURVIVE)." This system aims to address the high rates of relapse and treatment dropout for individuals with stimulant use disorder by incorporating cognitive...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $295,906 to Addinex Technologies, Inc. to integrate and assess a closed-loop medication management system for opioid pain management in ambulatory patients with extremity fractures being discharged from the emergency department. The project aims to adapt Addinex's existing medication dispensing platform to work within a hospital pharmacy setting,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $591,752 to Oprems LLC to develop and evaluate a digital platform for screening patients who receive prescribed opioid medications for potential risk of opioid misuse and overdose. The key products and services to be delivered under this grant include integrating the screening tools and process developed by Oprems' existing...
This federal Project Grant award, with ID R61DA061296, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,948,634 award will fund the development and evaluation of a mobile health (mHealth) intervention called "OD-CHESS" to reduce overdose risk among people who engage in polysubstance use. The project aims to adapt an existing substance use disorder intervention called A-CHESS into the OD-CHESS...
This Project Grant award of $373,181 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research focused on understanding the role of cholinergic interneurons in the ventral tegmental area that express mu-opioid receptors and their contribution to opioid reward, consumption, and withdrawal behaviors. The project aims to determine whether these interneurons and their mu-opioid receptors participate in opioid-related...